DSP Healthcare Fund Direct Growth
Equity
Direct
Sector - Healthcare
NAV: ₹ 22.1 as on 24-03-2023
Fund Performance
983 people have invested ₹ 38.2L in mutual fund in the last three months
Fund Insights
In the last 1 year, SBI Healthcare Opportunities Fund Direct Growth has given -2.81% return, outperforming DSP Healthcare Fund Direct Growth by 0.54%
In the last 3 years, DSP Healthcare Fund Direct Growth has outperformed all funds in its category
Over the last 1 month, DSP Healthcare Fund Direct Growth has increased expense ratio by 18.2% moving from 0.88 to 1.04
DSP Healthcare Fund Direct Growth has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 1.04% which is lower than the category average expense ratio of 1.67%
DSP Healthcare Fund Direct Growth Lumpsum Calculator
Fund Name
Expenses
CAGR Returns
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
Pros
3Y returns in the top 25% of the category
Among most bought funds within the category
Cons
No bad points found for this fund.
DSP Healthcare Fund Direct Growth Performance as on (24-Mar-23)
About the Fund
DSP Healthcare Fund Direct Growth is an equity fund. This fund was started on 30 November, 2018. The fund is managed by Jay Kothari, Vinit Sambre, Chirag Dagli. The fund could potentially beat inflation in the long-run.
Key parameters
1) DSP Healthcare Fund Direct Growth has a NAV of ₹22.089 as on 24-03-2023.
2) DSP Healthcare Fund Direct Growth has ₹1198 Cr worth of assets under management (AUM) as on 31-01-2023 and is less than category average.
3) The fund has an expense ratio 1.04 %.
DSP Healthcare Fund Direct Growth Overview
 | 1.04% |
 Benchmark | S&P BSE Healthcare PR |
 | ₹1198 Cr |
 | 30 November, 2018 |
 | ₹500/₹500 |
 Exit Load | 1% |
 | No Lock-in |
 TurnOver | 19.87% |
Fund Distribution as on (28-Feb-23)
Size breakup
Large cap
44.2%
Mid cap
27.9%
Small cap
27.3%
Sector Allocation
Health
97.8%
Financial Services
2.2%
Top Holdings of DSP Healthcare Fund Direct Growth as on (28-Feb-23)
Equity Holdings20
Holdings | Weight% | Holdings Trend | 1M Change |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 16.88% | 0% | |
 Cipla Ltd | 8.82% | 12.5% | |
 Apollo Hospitals Enterprise Ltd | 6.84% | 0% | |
 Procter & Gamble Health Ltd | 6.2% | 0% | |
 Lupin Ltd | 5.61% | 4.3% |
See all
DSP Healthcare Fund Direct Growth: Monthly Changes Updates
All changes are between Dec'22 and Feb'23
Fund Performance
- This fund’s returns stands at -3.00% whereas the fund’s underlying benchmark Nifty 500 returns stands at -2.22% as on Feb'23
- This fund underperformed Nifty 500 by 0.78% in Feb'23
AUM Change
- AUM of the fund stands at 1.2K Cr as of Feb'23
- AUM decreased by 33.2 Cr between Feb'23 and Jan'23
Fund Portfolio Changes
Top Stocks bought last month
Sun Pharmaceuticals Industries Ltd's allocation increased from 16.25% to 17.76%
Zydus Lifesciences Ltd's allocation increased from 2.06% to 3.37%
Suven Pharmaceuticals Ltd's allocation increased from 2.4% to 3.41%
Top Stocks sold last month
Cipla Ltd's allocation decreased from 9.08 % to 8.57 %
Apollo Hospitals Enterprise Ltd's allocation decreased from 6.79 % to 6.44 %
Vijaya Diagnostic Centre Ltd's allocation decreased from 3.63 % to 3.41 %
Mid Cap allocation has gone up from 27.9% to 27.9%
Large Cap allocation has gone down from 44.5% to 44.2%
Small Cap allocation has gone up from 25.1% to 27.3%
Cash allocation has gone down from 2.6% to 0.5%
Top 2 Sectors in February were Health, Financial Services
Feb'23
Health
98%
Financial Services
2%
Jan'23
Health
98%
Financial Services
2%
Gainers & Losers in DSP Healthcare Fund Direct Growth portfolio as on (28-Feb-23)
Top Growth Drivers | 1M Return |
|---|---|
 Procter & Gamble Health Ltd | 14.1% |
 Indoco Remedies Ltd | 10.5% |
 Zydus Lifesciences Ltd | 7% |
Peer Analysis
DSP Healthcare Fund Direct Growth Fund Manager
Jay Kothari
Fund Manager of DSP Healthcare Fund Direct Growth, since 30 November 2018
Top funds managed
Vinit Sambre
Fund Manager of DSP Healthcare Fund Direct Growth, since 30 November 2018
Top funds managed
Chirag Dagli
Fund Manager of DSP Healthcare Fund Direct Growth, since 1 December 2020
Top funds managed
Fund Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 20.18% since inception which is more than its category average return of 13.52%
Fund Allocations
This fund has an allocation of 99.47% in Equity, 0% in Debt and 0.53% in Cash related instruments
AUM size ₹1198 Cr
This fund has AUM of ₹1198 Cr which is less than its category average of ₹ 1251 Cr
Expense Ratio 1.04%
This fund has an expense ratio of 1.04% which is less than its category average expense ratio of 1.56%
Frequently Asked Questions
The current NAV of DSP Healthcare Fund Direct Growth is 22.09 as on 24-Mar-2023.
Existing (Absolute + CAGR)
DSP Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -1.74% | -1.74% |
6 Month Returns | 0.96% | 0.96% |
1 Year Returns | -3.35% | -3.35% |
3 Years Returns | 117.22% | 29.51% |
5 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.04 as on February 2023
1198 Cr as on February 2023
Sun Pharmaceuticals Industries Ltd(16.88%),Cipla Ltd(8.82%),Apollo Hospitals Enterprise Ltd(6.84%),Procter & Gamble Health Ltd(6.2%),Lupin Ltd(5.61%) as on February 2023
Health(97.25%),Financial Services(2.22%),Cash Equivalent(0.53%) as on February 2023
The alpha ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
DSP Healthcare Fund Direct Growth | 6.02 | 6.3 | - |
As on February 2023
The alpha for DSP Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
DSP Healthcare Fund Direct Growth | 0.98 | 0.79 | - |
As on February 2023
The Beta for DSP Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
DSP Healthcare Fund Direct Growth | -0.37 | 0.94 | - |
As on February 2023
The sharpe ratio for DSP Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the DSP Healthcare Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
DSP Healthcare Fund Direct Growth | 14.24 | 18.88 | - |
As on February 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.81 as on February 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.58 as on February 2023. It tells the consistency of the fund in generating superior risk-adjusted performance
Jay Kothari,Chirag Dagli,Vinit Sambre are the fund managers of DSP Healthcare Fund Direct Growth
The Exit load of DSP Healthcare Fund Direct Growth is 1%